Beveridge, Roy A is Director of Epizyme, Inc.. Currently has a direct ownership of 0 shares of EPZM, which is worth approximately $0. The most recent transaction as insider was on Aug 12, 2022, when has been sold 46,037 shares (Common Stock, par value $0.0001) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

BEVERIDGE, ROY A Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 12 2022
SELL
Sale (or disposition) back to the issuer
-
46,037 Reduced 100.0%
0 Common Stock, par valu...
Jun 30 2022
BUY
Grant, award, or other acquisition
$13,124 $1.47 p/Share
8,928 Added 16.24%
46,037 Common Stock, par valu...
May 17 2022
BUY
Grant, award, or other acquisition
-
8,994 Added 19.51%
37,109 Common Stock, par valu...
Mar 31 2022
BUY
Grant, award, or other acquisition
$13,125 $1.15 p/Share
11,413 Added 28.87%
28,115 Common Stock, par valu...
Nov 16 2021
BUY
Grant, award, or other acquisition
-
16,702 Added 50.0%
16,702 Common Stock, par valu...
BRA

Beveridge, Roy A

Director
Cambridge, MA

Track Institutional and Insider Activities on EPZM

Follow Epizyme, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EPZM shares.

Notify only if

Insider Trading

Get notified when an Epizyme, Inc. insider buys or sells EPZM shares.

Notify only if

News

Receive news related to Epizyme, Inc.

Track Activities on EPZM